KEM2105臨床試驗批準文件
KEM2105緩釋片一天僅需給藥一次，用于治療（16歲及以上）部分性發作的癲癇患者。原研速釋片目前僅在歐盟和美國上市，國內暫未上市。
文章鏈接：
https://doi.org/10.1016/j.ijpharm.2023.123301
文章信息：
Zhiyuan Hou,Xiaoxiao Cheng,Xiangcheng Zhao,Jianing Lin,Hailong Zhang,Youshan Li,Jinsong Ding.Design and evaluation of gastro-swelling/gastro-floating sustained-release tablets of brivaracetam for epilepsy therapy.Int J Pharm.2023,644:123301.
